Lead Sponsor

Vomaris Innovations

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

•Wound size greater than 1x1 cm
•Wounds must be ≥5 cm away from all other wounds
•Wound size must not be diminished in size greater than 10% between enrollment in study and the prescreening
•Participant must be candidate for negative pressure wound therapy
•Participant agrees to participate in follow-up evaluations
•Participant must be able to read and understand informed consent, and sign the informed consent

•Concurrent participation in another clinical trial that involves an investigational drug or device that would interfere with this study
•Participant is to receive another topical agent (antimicrobials, enzymes, etc.) other than the study dressing (granufoam)
•Participant is to receive Silver granufoam for their wound
•Participant with sensitivity or adverse reactions to silver or zinc
•Pregnancy or nursing an infant or child
•Immunosuppression
•Active or systemic infection
•Participant undergoing active cancer chemotherapy
•Chronic steroid use